Abstract:Polioviruses (PVs) are positive strand RNA viruses responsible for poliomyelitis. Many PVs have been isolated and phenotypically characterized in the 1940s-50s for the purpose of identifying attenuated strains that could be used as vaccine strains. Among these historical PVs, only few are genetically characterized. We report here the sequencing of four PV strains stored for more than 60 years in a sealed box. These PVs are cold variants that were selected by Albert Sabin based on their capacity to multiply at relatively low temperatures. Inoculation of permissive cells at 25°C showed that two of the four historical virus stocks still contained infectious particles. Both viruses reached titres that were higher at 25°C than at 37°C, thus demonstrating that they were genuine cold variants. We obtained sequences that span virtually all the genome for three out of the four strains; a short sequence that partly covers the 5' untranslated region was recovered for the last one. Unexpectedly, the genome of one historical cold variant (which derives from PV-3 Glenn) displayed a very high nucleotide identity (above 95%) with that of a PV strain (PV-3 strain WIV14) sampled in China in 2014 and then classified as a highly evolved vaccine-derived PV. Our analyses made this hypothesis very unlikely and strongly suggested that Glenn and WIV14 shared a very recent common ancestor with one another. Some strains used to produce the inactivated polio vaccine were also very close to Glenn and WIV14 in the capsid-encoding region, but they had not been sequenced beyond the capsid. We therefore sequenced one of these strains, Saukett A, which was available in our collection. Saukett A and WIV14 featured an identity higher than 99% at the nucleotide level. This work provides original data on cold variants that were produced and studied decades ago. It also highlights that sequences of historical PV strains could be crucial to reliably characterize contemporary PVs in case of release from a natural reservoir or from a facility, which is of highest importance for the PV eradication program.

[100 years of studying poliomyelitis virus and nonpoliomyelitis enteroviruses]

Opening a 60-year time capsule: sequences of historical poliovirus cold variants shed a new light on a contemporary strain

The pathogenesis of poliomyelitis: what we don't know

Non-Polio Enteroviruses Isolated by Acute Flaccid Paralysis Surveillance Laboratories in the Russian Federation in 1998–2021: Distinct Epidemiological Features of Types

The fight against poliomyelitis through the history: past, present and hopes for the future. Albert Sabin's missing Nobel and his "gift to all the world's children"

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?

Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus

Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses

Enteroviruses: epidemic potential, challenges and opportunities with vaccines

Israel in the elimination phase of poliomyelitis--achievements and remaining problems

[Historical, clinical and epidemiological aspects of poliomyelitis in Mexico (1946-1960)]

Antiviral Development for the Polio Endgame: Current Progress and Future Directions

Polio, public health memories and temporal dissonance of re-emerging infectious diseases in the global north

[Possible method of eradication of poliomyelitis as an infection]

Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans

Controversies in polio immunization

Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses

Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles

[Epidemiological analysis of non-enterovirus 71 and non-coxsackievirus A16 enterovirus]

Research Progress in Human Enterovirus Recombination